Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1994 Aug;57(8):911–913. doi: 10.1136/jnnp.57.8.911

Debrisoquine hydroxylase gene polymorphism in familial Parkinson's disease.

V Planté-Bordeneuve 1, M B Davis 1, D M Maraganore 1, C D Marsden 1, A E Harding 1
PMCID: PMC1073072  PMID: 8057112

Abstract

Recent molecular genetic studies of the cytochrome P-450 system enzyme CYP2D6, which hydroxylates debrisoquine, have indicated an excess of mutant alleles in patients with Parkinson's disease compared with controls. This indicates that the CYP2D6 locus confers genetic susceptibility to Parkinson's disease. CYP2D6 polymorphism has been investigated in 48 patients with familial Parkinson's disease, from 22 families, and 88 of their unaffected relatives. An excess of CYP2D6 mutant alleles in patients compared with healthy relatives was found only in subjects over the age of 60 years, presumably reflecting the age related prevalence of this disease. There was no difference in distribution of genotypes, however, between sib pairs concordant or discordant for Parkinson's disease. Linkage analysis, exclusively with affected family members, yielded negative lod scores. These data indicate that the CYP2D6 locus is not the major determinant of genetic susceptibility in familial Parkinson's disease.

Full text

PDF
911

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong M., Daly A. K., Cholerton S., Bateman D. N., Idle J. R. Mutant debrisoquine hydroxylation genes in Parkinson's disease. Lancet. 1992 Apr 25;339(8800):1017–1018. doi: 10.1016/0140-6736(92)90537-d. [DOI] [PubMed] [Google Scholar]
  2. Barbeau A., Cloutier T., Roy M., Plasse L., Paris S., Poirier J. Ecogenetics of Parkinson's disease: 4-hydroxylation of debrisoquine. Lancet. 1985 Nov 30;2(8466):1213–1216. doi: 10.1016/s0140-6736(85)90743-3. [DOI] [PubMed] [Google Scholar]
  3. Benitez J., Ladero J. M., Jimenez-Jimenez F. J., Martinez C., Puerto A. M., Valdivielso M. J., Llerena A., Cobaleda J., Muñoz J. J. Oxidative polymorphism of debrisoquine in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1990 Apr;53(4):289–292. doi: 10.1136/jnnp.53.4.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Burn D. J., Mark M. H., Playford E. D., Maraganore D. M., Zimmerman T. R., Jr, Duvoisin R. C., Harding A. E., Marsden C. D., Brooks D. J. Parkinson's disease in twins studied with 18F-dopa and positron emission tomography. Neurology. 1992 Oct;42(10):1894–1900. doi: 10.1212/wnl.42.10.1894. [DOI] [PubMed] [Google Scholar]
  5. Degl'Innocenti F., Maurello M. T., Marini P. A parkinsonian kindred. Ital J Neurol Sci. 1989 Jun;10(3):307–310. doi: 10.1007/BF02333776. [DOI] [PubMed] [Google Scholar]
  6. Ebers G. C., Paty D. W., Stiller C. R., Nelson R. F., Seland T. P., Larsen B. HLA-typing in multiple sclerosis sibling pairs. Lancet. 1982 Jul 10;2(8289):88–90. doi: 10.1016/s0140-6736(82)91702-0. [DOI] [PubMed] [Google Scholar]
  7. Gaedigk A., Blum M., Gaedigk R., Eichelbaum M., Meyer U. A. Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphism. Am J Hum Genet. 1991 May;48(5):943–950. [PMC free article] [PubMed] [Google Scholar]
  8. Golbe L. I., Di Iorio G., Bonavita V., Miller D. C., Duvoisin R. C. A large kindred with autosomal dominant Parkinson's disease. Ann Neurol. 1990 Mar;27(3):276–282. doi: 10.1002/ana.410270309. [DOI] [PubMed] [Google Scholar]
  9. Gough A. C., Miles J. S., Spurr N. K., Moss J. E., Gaedigk A., Eichelbaum M., Wolf C. R. Identification of the primary gene defect at the cytochrome P450 CYP2D locus. Nature. 1990 Oct 25;347(6295):773–776. doi: 10.1038/347773a0. [DOI] [PubMed] [Google Scholar]
  10. Hanioka N., Kimura S., Meyer U. A., Gonzalez F. J. The human CYP2D locus associated with a common genetic defect in drug oxidation: a G1934----A base change in intron 3 of a mutant CYP2D6 allele results in an aberrant 3' splice recognition site. Am J Hum Genet. 1990 Dec;47(6):994–1001. [PMC free article] [PubMed] [Google Scholar]
  11. Jenner P., Schapira A. H., Marsden C. D. New insights into the cause of Parkinson's disease. Neurology. 1992 Dec;42(12):2241–2250. doi: 10.1212/wnl.42.12.2241. [DOI] [PubMed] [Google Scholar]
  12. Kallio J., Marttila R. J., Rinne U. K., Sonninen V., Syvälahti E. Debrisoquine oxidation in Parkinson's disease. Acta Neurol Scand. 1991 Mar;83(3):194–197. doi: 10.1111/j.1600-0404.1991.tb04676.x. [DOI] [PubMed] [Google Scholar]
  13. Lathrop G. M., Lalouel J. M., Julier C., Ott J. Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci U S A. 1984 Jun;81(11):3443–3446. doi: 10.1073/pnas.81.11.3443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Maraganore D. M., Harding A. E., Marsden C. D. A clinical and genetic study of familial Parkinson's disease. Mov Disord. 1991;6(3):205–211. doi: 10.1002/mds.870060303. [DOI] [PubMed] [Google Scholar]
  15. Mutch W. J., Dingwall-Fordyce I., Downie A. W., Paterson J. G., Roy S. K. Parkinson's disease in a Scottish city. Br Med J (Clin Res Ed) 1986 Feb 22;292(6519):534–536. doi: 10.1136/bmj.292.6519.534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Sawle G. V., Wroe S. J., Lees A. J., Brooks D. J., Frackowiak R. S. The identification of presymptomatic parkinsonism: clinical and [18F]dopa positron emission tomography studies in an Irish kindred. Ann Neurol. 1992 Nov;32(5):609–617. doi: 10.1002/ana.410320503. [DOI] [PubMed] [Google Scholar]
  17. Smith C. A., Gough A. C., Leigh P. N., Summers B. A., Harding A. E., Maraganore D. M., Sturman S. G., Schapira A. H., Williams A. C., Maranganore D. M. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet. 1992 Jun 6;339(8806):1375–1377. doi: 10.1016/0140-6736(92)91196-f. [DOI] [PubMed] [Google Scholar]
  18. Steiger M. J., Lledo P., Quinn N. P., Marsden C. D., Turner P., Jenner P. G. Debrisoquine hydroxylation in Parkinson's disease. Acta Neurol Scand. 1992 Aug;86(2):159–164. doi: 10.1111/j.1600-0404.1992.tb05059.x. [DOI] [PubMed] [Google Scholar]
  19. Ward C. D., Duvoisin R. C., Ince S. E., Nutt J. D., Eldridge R., Calne D. B. Parkinson's disease in 65 pairs of twins and in a set of quadruplets. Neurology. 1983 Jul;33(7):815–824. doi: 10.1212/wnl.33.7.815. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES